Price $73.43 |
Market Cap
2.06B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
53.5
|
P/B
3.19
|
P/S
2.53
|
Dividend %
1.10%
|
|
P/CF
-
|
P/FCF
53.4
|
Op. Cash Flow
75.3K
|
FCF
1.3
|
|
Op. Margin
8.20%
|
Net Margin
8.70%
|
ROE
11.60%
|
ROI
3.70%
|
|
ROA
5.20%
|
EPS Growth
467.20%
|
Current Ratio
2.4
|
Debt/Equity
74.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.24 | - | - | 10M | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.12 | - | - | 1.1B | Strong Buy |
| Digirad Corporation (DRAD) | $1.62 | - | 14.20% | 33.7M | Strong Buy |
| Neurometrix Inc (NURO) | $1.27 | - | - | 9.7M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.25 | - | - | 40.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
